Saltar al contenido principal
World Congress on Medical Oncology
Olympic Paris 2024
Test 4
Test 1
Test 2
Test 5
Test 3
Test clone mv
Olympic Paris 2024
Olympic Paris 2024 - VIP - Boss Ticket
Olympic Paris 2024
Finance Code Test
Concrete Institute of Australia’s Biennial National Conference 2025
Concrete Institute of Australia’s Biennial National Conference 2025
Test Goldenowl Conference
Virtual Event 01
Paris Olypmpic Clone 12.09 webinar
7th World Congress of Nanoentomology
NDS NAB Transact testing
JC test 01
Pre-Release 3 Oct
DEX (Digital Employee Experience) conference 2024
test derek
TimeZone Test
TimeZone Test
Talent Events
Event Demo
Olympic Paris 2024 x
original event name for cloning testing
Olympic Paris 2024
Default payment method test
evexus Event - 509
Default payment method test2
Test Worker
Test Worker
charlie test
Arinex 1
NET24 Ho Chi Minh City Workshop 2024
Telefilm 2024 - International Exhibition of Film and Television Technology in Vietnam
Olympic Paris 2024
charlie test 2711
charlie test 2711 cloned
CICM SecurePay testing
The AI Submit 2024
Test webinar 04.12 - - - -
Taylor Swift Clone 04
Taylor Swift Clone 02
Taylor Swift
Taylor Swift Clone
Taylor Swift Clone 01
Import Test
The Trading Summit 2024 (HCM - Vietnam)
Electric Dreams: A Synthwave Extravaganza
Taylor Swift 16
Taylor Swift 12
Taylor Swift 14
Taylor Swift 15
Taylor Swift 17
Taylor Swift 20
Coin Based Hackathon 2024
Rose 01
Import Ticket
Vu Cat Tuong
STEM 1
Kids STEM
CLONE Innovate 2025: A Future Forward Summit
Innovate 2025: A Future Forward Summit
Petals & Sunshine Festival
webinar 05/02
Science
evexus Event - 273
evexus Event - 275
Association webinar 5.2
evexus Event - 274
Aurora Nights 2025 - Webinar
Seoul AI Seminar
Webinar Event - Lily AI - 20/02
evexus Event - 287
Taylor Swift 11
Swifties Only Social Contact
cloned event for Bree QA
evexus Event - 288
evexus Event - 289
Bree QA event
Tim's event
Ralph's event
Tim cloned enable all
Ralph clone event the last one
Hawaii AI Seminar
evexus Event - 293
Tokyo Seminar
Indiana AI Seminar
Registration ticket 2025
TechNova Summit
Event - 28 - 03 - 2025
TechNova Summit [2]
TechNova Summit [3]
Tech v1
Event 28/03/2025
Job Affairs
Fan Job
Webinar Event - Lily AI - 04/03
Event Registration
Association webinar 20.2
Fan's stock query
Registration
Aurora Nights 2025
Ralph test email
Taylor Swift 13
The Core 2025
Rose
The Thirdweb submit
Stress Test Conference 2026
World Congress of Medical Oncology
Alan'event
The AI Seoul Submit 2026
The Core 2026
Los horarios se muestran en su zona horaria local GMT
Normothermic Machine Perfusion Enables High-Risk Donation After Circulatory Death Liver Transplantation Without Compromising Biliary Outcomes
Poster
Talk Descripción

Institución: Austin Health - Victoria, Australia

Background Donation after circulatory death (DCD) liver transplant helps expand the donor pool but remains limited by conservative acceptance criteria due to high rates of ischemic complications such as non-anastomotic biliary strictures. This study aimed to document the experience of an Australian liver transplant center comparing the outcomes of transplants conducted using DCD grafts preserved with back-to-base normothermic machine perfusion (NMP) and standard cold storage (SCS). Methods A retrospective cohort study was assessing DCD liver transplant outcomes performed between 2015 and 2024 with grafts preserved using NMP (n=37) or SCS (n=26). The primary outcome was non-anastomotic biliary stricture development and secondary outcomes included traditional liver transplant outcomes such as graft and patient mortality, complications, and early allograft dysfunction (EAD). Results There was no statistically significant difference in the development of clinically significant NAS requiring intervention (NASc) or radiological NAS (NASr) between NMP and SCS (NASc: 8.1% vs 23.1%; p=0.192; NASr: 24.3% vs 30.8%; p=0.780). The NMP group had higher donor risk index (2.2 vs 1.8, p=0.014) and model for end-stage liver disease scores (19.9 vs 13.6; p=0.029) and developed less EAD relative to the SCS group (13.5% vs 73.1%, p<0.001). Longer cold ischemia time was associated with odds of developing NASc (multivariate OR [95% CI]: 1.02 [1.00–1.03]; p=0.034). There were no differences in patient and graft survival, complications, retransplantation, or length of stay between preservation groups. Conclusion NMP use facilitates high-risk DCD transplant, despite a higher risk donor and recipient cohort there was no compromise in biliary outcomes and EAD relative to the SCS group. Further research directed towards on-pump viability assessment and efforts to minimize ischemic time will likely improve graft selection and outcomes as the extended criteria transplant practice expands.
Speakers
Contributors
Authors

Dr Robert Torode - , Dr Je Min Suh - , Dr Minu Alwis - , Dr Eunice Lee - , Dr Ruelan Furtado - , Prof Laurence Weinberg - , A/Prof Michael Fink - , Prof Robert Jones - , Dr Graham Starkey - , Prof Marcos Perini -

Otro Sugerido ePosters
Privacy Statement Header

By confirming your acceptance below, you agree to our Privacy Policy